dual-specificity-protein-kinase-zaka-zaka

Description: Recombinant human ZAK, variant 2, full length, with N-terminal GST-tag, expressed in Sf9 insect cells via a baculovirus expression system.

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: A polyclonal antibody against ZAK. Recognizes ZAK from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/40000

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: A polyclonal antibody against ZAK. Recognizes ZAK from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IF, ELISA;WB:1/500-1/2000.IF:1/200-1/1000.ELISA:1/20000

Description: Rabbit polyclonal ZAK antibody

Description: Purified Polyclonal ZAK antibody

Description: Antibody raised against ZAK

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: ZAK (Ab-165) Antibody

Description: ZAK/MLKLAK is a member of the MAPKKK family of signal transduction molecules. It possesses an N-terminal kinase catalytic domain, followed by a leucine zipper motif and a sterile-alpha motif (SAM). This magnesium-binding protein forms homodimers and is located in the cytoplasm. The protein mediates gamma radiation signaling leading to cell cycle arrest and activity of this protein plays a role in cell cycle checkpoint regulation in cells. The protein also has pro-apoptotic activity.

Description: ZAK/MLKLAK is a member of the MAPKKK family of signal transduction molecules. It possesses an N-terminal kinase catalytic domain, followed by a leucine zipper motif and a sterile-alpha motif (SAM). This magnesium-binding protein forms homodimers and is located in the cytoplasm. The protein mediates gamma radiation signaling leading to cell cycle arrest and activity of this protein plays a role in cell cycle checkpoint regulation in cells. The protein also has pro-apoptotic activity.

Description: Human ZAK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Description: Available in various conjugation types.

Description: Human ZAK knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Description: Description of target: Stress-activated component of a protein kinase signal transduction cascade. Regulates the JNK and p38 pathways. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14. Pro-apoptotic. Role in regulation of S and G2 cell cycle checkpoint by direct phosphorylation of CHEK2. Involved in limb development.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Competitive ELISA;Sensitivity: 0.156 ng/mL

Description: ZAK is a member of the MAPKKK family of signal transduction molecules and mediates gamma radiation signaling leading to cell cycle arrest. The activity of ZAK plays a role in cell cycle checkpoint regulation as well as being involved in regulating actin organization . Expression of kinase-dead ZAK in mouse fibroblasts disrupts actin stress fibers and causes morphologic changes. ZAK can activate JNK through MKK4/MKK7 and ERK5/p38-gamma via MKK3/MKK6. Expression of ZAK increases the population of cells in the G2/M phase of the cell cycle, whereas dominant-negative ZAK attenuated the G2 arrest caused by gamma radiation .

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to ATTO 565.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to ATTO 633.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to ATTO 655.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to ATTO 680.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to ATTO 700.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to Alkaline Phosphatase.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to APC .

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to APC/Cy7.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to Dylight 350.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to Dylight 405.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to Dylight 488.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to Dylight 594.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to Dylight 633.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to HRP.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to PE/ATTO 594.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to PerCP.

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to RPE .

Description: A polyclonal antibody for ZAK (pThr161+pThr162) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr161 and Thr162 of human MLTK (AA158-165). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This ZAK (pThr161+pThr162) antibody is conjugated to Streptavidin.